Chymase increases glomerular albumin permeability via protease-activated receptor-2

被引:19
作者
Sharma, Ram
Prasad, Vidudala
McCarthy, Ellen T.
Savin, Virginia J.
Dileepan, Kottarappat N.
Stechschulte, Daniel J.
Lianos, Elias
Wiegmann, Thomas
Sharma, Mukut
机构
[1] Kansas City VA Med Ctr, Renal Res Lab, Kansas City, MO 64128 USA
[2] Kansas City VA Med Ctr, Neurobiol Res Lab, Kansas City, MO 64128 USA
[3] Univ Kansas, Med Ctr, Div Nephrol, Kansas City, KS 66103 USA
[4] Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA
[5] Univ Kansas, Med Ctr, Dept Med, Div Allergy Clin Immunol & Rheumatol, Kansas City, KS 66103 USA
[6] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Nephrol, New Brunswick, NJ 08903 USA
关键词
chymase; protease-activated receptors; glomerular albumin permeability;
D O I
10.1007/s11010-006-9342-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Increased infiltration of the kidney by mast cells is associated with proteinuria, and interstitial fibrosis in various renal diseases. Mast cells produce serine proteases including tryptase and chymase (MCC) that act via protease-activated receptors (PARs) to induce synthesis of fibrogenic cytokines by renal cells. In the present study, we investigated direct effect of MCC and role of PARs on glomerular albumin permeability (P-alb). Isolated rat glomeruli were incubated with MCC (0.1, 1, 10, and 100 ng/ml) for 5-30 min in presence or absence of PAR-1 and PAR-2 blocking antibodies. P-alb was determined from the change in glomerular volume in response to an albumin oncotic gradient. The effect of direct activation of PARs on P-alb was verified by incubating glomeruli with synthetic hexapeptide known to activate PAR-1 and PAR-2. MCC increased P-alb of isolated rat glomeruli in a dose- and time-dependent manner. Blocking PAR-2 prevented MCC-mediated increase in P-alb. RT-PCR analysis of glomerular RNA demonstrated the presence of constitutively expressed PAR-1, -2, and -3 and low levels of PAR-4. In addition, direct activation of PAR-2 by hexapeptide SLIGKV increased P-alb comparable to MCC, whereas PAR-1 activation by TFLLRN had no effect on P-alb. Our results document that MCC induces increase in P-alb and that this effect is mediated through PAR-2. MCC may also play a role in renal scarring. We propose that inhibiting MCC activity or blocking the activation of PAR-2 may provide new targets for therapy in renal diseases.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 49 条
[21]   Protease-activated receptor 3 is a second thrombin receptor in humans [J].
Ishihara, H ;
Connolly, AJ ;
Zeng, DW ;
Kahn, ML ;
Zheng, YW ;
Timmons, C ;
Tram, T ;
Coughlin, SR .
NATURE, 1997, 386 (6624) :502-506
[22]   Mast cell infiltration and chemokine expression in progressive renal disease [J].
Jones, SE ;
Kelly, DJ ;
Cox, AJ ;
Zhang, Y ;
Gow, RM ;
Gilbert, RE .
KIDNEY INTERNATIONAL, 2003, 64 (03) :906-913
[23]   A dual thrombin receptor system for platelet activation [J].
Kahn, ML ;
Zheng, YW ;
Huang, W ;
Bigornia, V ;
Zeng, DW ;
Moff, S ;
Farese, RV ;
Tam, C ;
Coughlin, SR .
NATURE, 1998, 394 (6694) :690-694
[24]  
Kondo S, 2001, J AM SOC NEPHROL, V12, P1668, DOI 10.1681/ASN.V1281668
[25]  
Lajoie G, 1996, MODERN PATHOL, V9, P1118
[26]   POLYMORPHONUCLEAR LEUKOCYTES INCREASE GLOMERULAR ALBUMIN PERMEABILITY VIA HYPOHALOUS ACID [J].
LI, JZ ;
SHARMA, R ;
DILEEPAN, KN ;
SAVIN, VJ .
KIDNEY INTERNATIONAL, 1994, 46 (04) :1025-1030
[27]  
McCarthy ET, 1998, J AM SOC NEPHROL, V9, P433
[28]   Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier [J].
McCarthy, ET ;
Sharma, R ;
Sharma, M .
KIDNEY INTERNATIONAL, 2005, 67 (01) :152-156
[29]   Trypsin stimulates integrin α5β1-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2 [J].
Miyata, S ;
Koshikawa, N ;
Yasumitsu, H ;
Miyazaki, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4592-4598
[30]   Local angiotensin II-generating system in vascular tissues: The roles of chymase [J].
Miyazaki, MA ;
Takai, S .
HYPERTENSION RESEARCH, 2001, 24 (03) :189-193